相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
Bryan J. Neth et al.
PHARMACEUTICS (2023)
Long-Acting Recombinant Human Interleukin-7, NT-17, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models
Jian L. Campian et al.
CLINICAL CANCER RESEARCH (2022)
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Stephen J. Bagley et al.
CLINICAL CANCER RESEARCH (2022)
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2022)
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies
Erik H. P. van Putten et al.
CLINICAL CANCER RESEARCH (2022)
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice
Laura Evgin et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
Ugur Sener et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Intratumoral oncolytic herpes virus G47 increment for residual or recurrent glioblastoma: a phase 2 trial
Tomoki Todo et al.
NATURE MEDICINE (2022)
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
Jaime Gallego Perez-Larraya et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
A phase I/II study of triple-mutated oncolytic herpes virus G47 increment in patients with progressive glioblastoma
Tomoki Todo et al.
NATURE COMMUNICATIONS (2022)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2022)
CTIM-20. FINAL RESULTS OF CONTROLLED IL-12 MONOTHERAPY AND IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA
Rimas Lukas et al.
NEURO-ONCOLOGY (2021)
Convection-enhanced drug delivery for glioblastoma: a review
Randy S. D'Amico et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology
Aline P. Becker et al.
CANCERS (2021)
Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
Laura Evgin et al.
CANCERS (2021)
Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer
Sara A. Collins et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
Shoh Yajima et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
First-in-human CAN-3110 (ICP-34.5 expressing HSV-1 oncolytic virus) in patients with recurrent high-grade glioma.
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
Jawad Fares et al.
LANCET ONCOLOGY (2021)
Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis
Toshihiro Uchihashi et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Survival of subjects with recurrent glioblastoma receiving intratumoral administration of controlled IL-12 with limited exposure to dexamethasone.
Rimas Vincas Lukas et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
E. Antonio Chiocca et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer
Kotaro Sugawara et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
Qing Zhang et al.
CELL DEATH & DISEASE (2020)
Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy
Pei Zhang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
June Kyu Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma A Randomized Clinical Trial
Timothy F. Cloughesy et al.
JAMA ONCOLOGY (2020)
The landscape of the mesenchymal signature in brain tumours
Jinan Behnan et al.
BRAIN (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma
Mark W. Kieran et al.
NEURO-ONCOLOGY (2019)
Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus
Yang Yan et al.
BIOSCIENCE REPORTS (2019)
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
John A. Barrett et al.
CANCER GENE THERAPY (2018)
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment
Gerald Moncayo et al.
NEURO-ONCOLOGY (2018)
Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
Timothy F. Cloughesy et al.
NEURO-ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
Giulia Marelli et al.
FRONTIERS IN IMMUNOLOGY (2018)
Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
Carole Achard et al.
EBIOMEDICINE (2018)
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Pakawat Chongsathidkiet et al.
NATURE MEDICINE (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs
Michael C. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in Glioma
Abir Mondal et al.
FRONTIERS IN ONCOLOGY (2017)
Phase I trial of gene-mediated cytotoxic immunotherapy in combination with chemoradiation for locally advanced pancreatic cancer.
M. Bloomston et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas
Vidyalakshmi Chandramohan et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Plasma Pharmacokinetics of Veledimex, a Small-Molecule Activator Ligand for a Proprietary Gene Therapy Promoter System, in Healthy Subjects
Hongliang Cai et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Phase 1b open-label randomized study of the oncolytic adenovirus DNX-2401 administered with or without interferon gamma for recurrent glioblastoma.
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma
Nan Ji et al.
ONCOTARGET (2016)
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Lee A. Wheeler et al.
NEURO-ONCOLOGY (2016)
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
Daxa M. Patel et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2016)
Going viral: a review of replication-selective oncolytic adenoviruses
Christopher Larson et al.
ONCOTARGET (2015)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
INTRATUMORAL DELIVERY OF THE RETROVIRAL REPLICATING VECTOR (RRV) TOCA 511 IN SUBJECTS WITH RECURRENT HIGH GRADE GLIOMA: INTERIM REPORT OF PHASE 1 STUDY (NCT 01156584)
Manish Aghi et al.
NEURO-ONCOLOGY (2014)
Evaluation of the Safety and Biodistribution of M032, an Attenuated Herpes Simplex Virus Type 1 Expressing hIL-12, After Intracerebral Administration to Aotus Nonhuman Primates
Justin C. Roth et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection
Johannes vom Berg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
A Preclinical Evaluation of Neural Stem CellBased Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
Atique U. Ahmed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
K. B. Stephenson et al.
CANCER GENE THERAPY (2012)
Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
Derek Ostertag et al.
NEURO-ONCOLOGY (2012)
Cytotoxic Immunotherapy Strategies for Cancer: Mechanisms and Clinical Development
Laura K. Aguilar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Impact of tumor microenvironment on oncolytic viral therapy
Jeffrey Wojton et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
Robin J. Prestwich et al.
HUMAN GENE THERAPY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL leads to enhanced cancer cell killing in human glioblastoma models
Martin E. Wohlfahrt et al.
CANCER RESEARCH (2007)
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2007)
History of oncolytic viruses: Genesis to genetic engineering
Elizabeth Kelly et al.
MOLECULAR THERAPY (2007)
The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma
WJ van Houdt et al.
JOURNAL OF NEUROSURGERY (2006)
Beyond oncolytic virotherapy: Replication-competent retrovirus vectors for selective and stable transduction of tumors
C Dalba et al.
CURRENT GENE THERAPY (2005)
Oncolytic herpes simplex virus vector G47Δ in combination with androgen ablation for the treatment of human prostate adenocarcinoma
H Fukuhara et al.
CLINICAL CANCER RESEARCH (2005)
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir
P Chévez-Barrios et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy
DH Sterman et al.
CLINICAL CANCER RESEARCH (2005)
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model
EK Hellums et al.
NEURO-ONCOLOGY (2005)
Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain
R Liu et al.
GENE THERAPY (2005)
An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor
H Kambara et al.
CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells
DH Qiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up
A Hasenburg et al.
GYNECOLOGIC ONCOLOGY (2001)
Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: Results of a phase I clinical trial
MW Sung et al.
MOLECULAR THERAPY (2001)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
T Todo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular genetics of radiographically defined de novo glioblastoma multiforme
A Tortosa et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor
K Asaoka et al.
JOURNAL OF NEUROSURGERY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors
TW Trask et al.
MOLECULAR THERAPY (2000)
An implantable guide-screw system for brain tumor studies in small animals
S Lal et al.
JOURNAL OF NEUROSURGERY (2000)
Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models
MJ Staba et al.
CANCER GENE THERAPY (2000)
分享论文
